Back to Search
NIPUNIE RAJAPAKSE, MD MPH
MD MPH
Pediatric Infectious Diseases Physician
NPI: 1679029581Individual
Specialties, Licenses & Credentials
Pediatric Infectious Diseases PhysicianPrimary
Pediatrics — Pediatric Infectious Diseases
Code: 2080P0208X
109010(MN)61180(MN)
Research & Publications (20)
Angiotensin II and neurohumoral control of the renal medullary circulation.
PMID 19566838·Clin Exp Pharmacol Physiol·2010
6-review
The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.
PMID 19375915·Bioorg Med Chem Lett·2009
8-other
Effect of spongin derived from Hymeniacidon sinapium on bone mineralization.
PMID 19165732·J Biomed Mater Res B Appl Biomater·2009
7-preclinical
Anti-inflammatory effect of Ishige okamurae ethanolic extract via inhibition of NF-kappaB transcription factor in RAW 264.7 cells.
PMID 19117331·Phytother Res·2009
7-preclinical
Role of L-arginine in nitric oxide production in health and hypertension.
PMID 19076168·Clin Exp Pharmacol Physiol·2009
6-review
A coupled analytical model for hydrostatic response of 1-3 piezocomposites.
PMID 18986927·IEEE Trans Ultrason Ferroelectr Freq Control·2008
8-other
Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.
PMID 18981330·Hypertension·2008
7-preclinical
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling.
PMID 18205790·Immunology·2008
7-preclinical
Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
PMID 18802025·Circ Res·2008
7-preclinical
Sulfated glucosamine inhibits oxidation of biomolecules in cells via a mechanism involving intracellular free radical scavenging.
PMID 18036590·Eur J Pharmacol·2008
7-preclinical
Suppression of cytokine production in lipopolysaccharide-stimulated mouse macrophages by novel cationic glucosamine derivative involves down-regulation of NF-kappaB and MAPK expressions.
PMID 18786831·Bioorg Med Chem·2008
7-preclinical
Glucosamine sulfate promotes osteoblastic differentiation of MG-63 cells via anti-inflammatory effect.
PMID 17270442·Bioorg Med Chem Lett·2007
8-other
An in vitro cellular analysis of the radical scavenging efficacy of chitooligosaccharides.
PMID 17475286·Life Sci·2007
8-other
Inhibition of free radical-mediated oxidation of cellular biomolecules by carboxylated chitooligosaccharides.
PMID 17084635·Bioorg Med Chem·2007
7-preclinical
Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.
PMID 17498959·Bioorg Med Chem·2007
8-other
Effect of methyl jasmonate on secondary metabolites of sweet basil (Ocimum basilicum L.).
PMID 16536615·J Agric Food Chem·2006
8-other
Carboxy derivatized glucosamine is a potent inhibitor of matrix metalloproteinase-9 in HT1080 cells.
PMID 16616490·Bioorg Med Chem Lett·2006
8-other
Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity.
PMID 16737716·Life Sci·2006
8-other
ANG II type 2 receptors and neural control of intrarenal blood flow.
PMID 16857892·Am J Physiol Regul Integr Comp Physiol·2006
7-preclinical
Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1.
PMID 17020790·Biochim Biophys Acta·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1679029581
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile